Assert-IQ vs PMcardio
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if you require long-term, continuous cardiac monitoring for patients with suspected heart rhythm disorders or those at risk for arrhythmias like atrial fibrillation. Its minimally invasive insertion and battery life of up to six years make it ideal for extended diagnostic evaluation and management, including remote monitoring and proactive clinician alerts.
View Assert-IQ →Choose PMcardio if…
Choose PMcardio if you need rapid, AI-powered interpretation of ECGs for immediate assessment of over 50 cardiac conditions at the point of care. Its mobile app and web platform are well-suited for emergency physicians, general practitioners, nurses, and paramedics who need quick, expert-level insights to make confident clinical decisions, especially in acute settings.
View PMcardio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
PMcardioPMcardio offers a mobile app for both iOS and Android, as well as a web platform, allowing for flexible access and immediate use without IT integration. Assert-IQ, while having a patient-facing mobile app, primarily relies on an implantable device and a clinician-facing system (Merlin.net PCN) for data review and programming, which suggests a more involved setup and less immediate usability for a broad range of clinicians.
Clinical Value
PMcardioPMcardio is clinically validated in over 25 studies and trusted by over 100,000 clinicians, offering instant AI-powered ECG interpretations for over 50 cardiac conditions, including advanced detection of STEMI/OMI and reduced LVEF. Assert-IQ focuses on long-term continuous monitoring for arrhythmia detection with AI algorithms to reduce false positives, and has demonstrated high sensitivity in AF detection in post-market studies. However, PMcardio's broader diagnostic scope and extensive validation in various acute settings suggest a wider immediate clinical impact.
Pricing & Value
PMcardioPMcardio offers a transparent freemium model with a free plan for up to 5 ECG analyses per month and a clear pricing structure for individual and team subscriptions. Assert-IQ uses an enterprise pricing model, requiring direct contact with Abbott Medical for institutional pricing, which lacks transparency for individual users or smaller practices. PMcardio's accessible entry point and clear pricing provide better value for a wider range of users.
Enterprise Readiness
PMcardioPMcardio offers enterprise integrations with EHR/CVIS and EMS systems, supports unlimited users and locations for organizations, and is built with SOC 2, ISO 27001, GDPR, and HIPAA compliance. Assert-IQ targets large health systems, hospitals, and cardiology clinics, is HIPAA compliant, and FDA cleared, but the available information doesn't detail the breadth of its enterprise integration capabilities beyond its proprietary Merlin.net PCN.
Innovation
PMcardioPMcardio demonstrates strong innovation with features like ECGxplainu2122 for visual AI explainability with heatmaps, Culprit Artery AI confidence scores with 3D heart visualization, and detection of 50+ ECG findings including reduced LVEF from ECGs. Assert-IQ's innovation lies in its long-term continuous monitoring (up to 6 years) and advanced AI algorithms to reduce false positives in arrhythmia detection. However, PMcardio's explainable AI and broader diagnostic capabilities represent a more cutting-edge approach to ECG interpretation.
Support & Docs
TieBoth tools provide substantial documentation. Assert-IQ offers clinician manuals, help manuals for its patient care systems, and patient information guides. PMcardio provides a help center with articles on getting started, instructions for use, and FAQs, along with legal documents. Both appear to offer adequate resources for users, with no clear differentiator in the depth or accessibility of their support and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | PMcardio |
|---|---|---|
| Name | Assert-IQ | PMcardio |
| Company | Abbott Medical | Powerful Medical |
| Description | The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | PMcardio is a CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians, it delivers rapid, expert-level interpretations, empowering various healthcare professionals to act with confidence at the point of care. |
| Free Trial | no | Not specified |
| Key Features | Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion | Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps, Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies), Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and PMcardio.